Zwycięstwo w Bukareszcie i zaczyn nowego W 2020 weszliśmy rozpędem, wieńcząc intensywny koniec poprzedniego roku zwycięstwem naszej spółki portfelowej 2040.io w konkursie organizowanym przez UIPath – światowego lidera RPA –...
“Innovation is available everywhere but more outside than inside. Global and regional companies are making use of this fact. Therefore the importance of well positioned start-up and CRO companies is increasing especially in the healthcare industry. Building an internal product portfolio connected with the ability to deliver end to end services are key success and growth factors for PozLab, AMS and CBBM.” – George Shlieout.
We are happy to announce that as of the 1st of October, Dr George Shlieout took up the role of CEO in PozLab and shall lead its business development and manage its daughter companies: CBBM and Applied Manufacturing Science.
Until mid of 2020 George had a leadership role in Abbott Laboratories Established Pharmaceutical Division (EPD) acting for many years as head of the global pharmaceutical development and head of several global development centres. In addition, George led the global Technical Transfer Organization.
George has extensive experience in developing pharmaceutical products for small and large molecules from early development stage until commercialization. He developed several products for Abbott Laboratories, which were successfully commercialized in different regions (EU, USA and emerging market).
“Our business goal is to deliver end to end services for the pharmaceutical industry in the region and to build up an internal IP portfolio. Main focus in the short time perspective is to increase internal agility and to build strategic partnerships to support growth of the business. The organisation has the appropriate expertise, technology platforms and committed and engaged personnel. We plan to increase visibility of the three organisations and combine revenue growth and profit-making with the need to support the people who make up our environment.
In the mid-term perspective we shall expand our operations onto newly defined niches in order to build a competitive edge for PozLab that will respond to market demand and be visible on the map of European CRO companies”- George Shlieout.
PozLab is one the leading CRO companies in Poland providing services in drug development, quality control and manufacturing for clinical purposes. CBBM specialises in microbiology contract services and APPLIED MANUFACTURING SCIENCE (AMS) AMS applies solubility enhancement technologies. All three are YouNick Mint portfolio companies.